ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Calliditas Therapeutics Ab

Calliditas Therapeutics Ab (0A5R)

0.00
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

0A5R Latest News

FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy

FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy PR Newswire STOCKHOLM, Aug. 18, 2023 STOCKHOLM, Aug. 18, 2023 /PRNewswire/ -- Calliditas Therapeutics...

FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy

FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy PR Newswire STOCKHOLM, Aug. 18, 2023 STOCKHOLM, Aug. 18, 2023 /PRNewswire/ -- Calliditas Therapeutics...

Interim Report Q2, 2023: Calliditas Therapeutics

Interim Report Q2, 2023: Calliditas Therapeutics PR Newswire STOCKHOLM, Aug. 17, 2023 Filing for full approval of TARPEYO STOCKHOLM, Aug. 17, 2023 /PRNewswire/ -- FINANCIAL SUMMARY FOR THE...

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet PR Newswire STOCKHOLM, Aug. 15, 2023 STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas...

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet PR Newswire STOCKHOLM, Aug. 15, 2023 STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas...

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib PR Newswire STOCKHOLM, July 13, 2023 STOCKHOLM, July 13, 2023...

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib PR Newswire STOCKHOLM, July 13, 2023 STOCKHOLM, July 13, 2023...

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO® PR Newswire STOCKHOLM, June 21, 2023 STOCKHOLM, June 21, 2023...

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO® PR Newswire STOCKHOLM, June 21, 2023 STOCKHOLM, June 21, 2023...

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ) PR Newswire STOCKHOLM, May 30, 2023 STOCKHOLM, May 30, 2023 /PRNewswire/ -- The following resolutions were passed at...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0A5R - Frequently Asked Questions (FAQ)

What is the current Calliditas Therapeutics Ab share price?
The current share price of Calliditas Therapeutics Ab is SEK 0.00
What is the 1 year trading range for Calliditas Therapeutics Ab share price?
Calliditas Therapeutics Ab has traded in the range of SEK 0.00 to SEK 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RAIRa International Group Plc
1.00p
(25.00%)
1.68M
ORCPOracle Power Plc
0.021p
(20.69%)
479.17M
EUAEurasia Mining Plc
6.00p
(20.00%)
79.48M
GFINGfinity Plc
0.12p
(20.00%)
73.7M
BELLBelluscura Plc
2.25p
(18.42%)
5.92M
GUSGusbourne Plc
22.00p
(-42.11%)
476.8k
NTVONativo Resources Plc
0.0014p
(-17.65%)
5.65B
PPSProton Motor Power Systems Plc
0.125p
(-16.67%)
1.24M
GALGalantas Gold Corporation
2.25p
(-13.46%)
88.5k
AFPAfrican Pioneer Plc
1.00p
(-13.04%)
1.2M
NTVONativo Resources Plc
0.0014p
(-17.65%)
5.65B
SYMESupply@me Capital Plc
0.0023p
(2.22%)
686.83M
ORCPOracle Power Plc
0.021p
(20.69%)
479.17M
MSMNMosman Oil And Gas Limited
0.0385p
(-3.75%)
278.06M
TRPTower Resources Plc
0.0275p
(-3.51%)
190.68M

Discussion

View Full Feed
Rosym Rosym 3 minutes ago
Nio's swap stations in Shanghai close to profitability, CEO says
Nio currently provides more than 9,000 battery swaps per day in Shanghai.
Shanghai has the largest number of NIO battery swap stations at 183.
The trend in the battery swap business is getting better, and Nio's (N
NIO
Wayne R Wayne R 3 minutes ago
Those 50 million shares that convert and have a bottom conversion price of 0.21....

That leaves us where?
MULN
StayHumble StayHumble 4 minutes ago
"I ShortNaked🔥24/7" tops the list per X MorganStanleyEmployee
“Gaming Wall Street”- HBO Documentary


Ex Morgan Stanley employee explains the situation about shorting and naked shorting perfectly!


Again, this is a MUST WATCH video f
RIGATONI RIGATONI 4 minutes ago
Congrats to the Philadelphia Eagles for...

Crushing the Referees chances of giving the game to KC

Tremendous win, writing was on the wall


~Rig
Invest-in-America Invest-in-America 5 minutes ago
MGOL: Now 65%, but WOW nonetheless!!
MGOL
patrik patrik 5 minutes ago
Typical Kim PR. Always something new and shiny to announce before
Ever selling anything. Hope it’s not a smokescreen in regards to his selling
of any spider silk. I have my doubts.
Patrik
KBLB
Monksdream Monksdream 6 minutes ago
Don’t see a reason why that shouldn’t’ happen
ruskie1 ruskie1 6 minutes ago
I could not agree more… this idiot CEO Thompson has had more than enough time to generate his 1 1/2 tons of silk to make a sale with somebody… it’s very apparent. This is going to be years and years of lab news after lab news after lab news….. there’s no way in the world he’s telling the truth to h
KBLB
georgie18 georgie18 6 minutes ago
Good Morning...🥳
trader_ron trader_ron 6 minutes ago
$ADHC American Diversifield Holdings Corporation Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program
https://www.otcmarkets.com/stock/ADHC/news/story?e&id=3125636
ADHC
trader_ron trader_ron 6 minutes ago
$ADHC American Diversifield Holdings Corporation Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program
https://www.otcmarkets.com/stock/ADHC/news/story?e&id=3125636
ADHC
StayHumble StayHumble 7 minutes ago
Wow✅Green's Great! 💹Xperts are Short✅$30 Incoming💹wow
MJNA
capgain capgain 7 minutes ago
Classic worth watching again!

https://www.youtube.com/shorts/eluMM1gtQtc
Hi_Lo Hi_Lo 9 minutes ago
Where are the missing CNNA financials since 2022?

Where are the missing CNNA financials for 2016 and 2017?

Where's Pink Limited?

Where's Pink Current?

Where's CNNA's SEC Form 10 registration statement approval that's been hyped by pumpers h
CNNA
Bud-Wiser Bud-Wiser 10 minutes ago
Go get him Tiger 🐅- that should scare him ...ROTF LMFDO -BWAHAHHAHAHHA
YCRM
Hi_Lo Hi_Lo 10 minutes ago
https://www.securitieslawyer101.com/2023/shell-hijacker-mark-miller-sentenced-to-one-year-in-prison/

Court documents show that Capitol Capital Corporation received several big chunks of stock in IGEX, then transferred the shares to Tiger Trout Capital LLC, a Puerto Rican entity contro
CNNA IGEX MEDH
polska polska 10 minutes ago
DNA and SV40 (cancer promoter) contamination in the Covid mRNA vaccines will generate many customers!
NWBO
MiamiGent MiamiGent 10 minutes ago
Yup, my next door neighbor was a foreman with Perini Construction in Boston. They did road work, put down roads. At retirement, his knees were shot from standing on cement all those years. But he had a long retirement. He just wabbled slowly.
buysellrepeat buysellrepeat 11 minutes ago
100% right imo 
ATWT
ksquared ksquared 11 minutes ago
Stinking animals. I can't stand Philly fans... they're the same for all sports.
Rowdy Eagles Fans Clash with Police, Destroy Property as Super Bowl Chaos Descends on Philly
DYLAN GWINN 9 Feb 2025 1:55

Thousands of Eagles fans spilled out of bars and onto
WebSlinger WebSlinger 13 minutes ago
>

It is pretty simple. I have posted the URLs to the SEC filings. All you need to do is click on the link and search for the text.
KBLB
uranium-pinto-beans uranium-pinto-beans 13 minutes ago
$MCD - McDonald's Q4 Results

🔸 Comparable Sales: +0.4% (vs. +3.4% last year, est. -0.93%)
• US: -1.4% (vs. +4.3% last year, est. -0.41%)
• International Operated Markets: +0.1% (vs. +4.4% last year, est. -1.14%)
• International Developmental Licensed Mar
MCD
docj docj 14 minutes ago
It is a public message board. Speculative comments are expected and welcome. What doesn't serve much purpose is people repeating their old grievances. At some point people should move on as hanging on to that old baggage is unhealthy. You have to let the Cytodyn team do their thing and we'll see whe
CYDY

Your Recent History

Delayed Upgrade Clock